Select your country or region
- Africa
- America
- Asia
- Europe
- Oceania
- Australia
- New Zealand
- Andorra
- Austria
- Czech Republic
- Denmark
- Finland
- France
- Germany
- Gibraltar
- Iceland
- Ireland
- Italy
- Norway
- Poland
- Portugal
- San Marino
- Slovakia
- Spain
- Sweden
- Switzerland
- UK
- Vaticano
- Argentina
- Aruba
- Bolivia
- Brazil
- Canada
- Chile
- Colombia
- Costa Rica
- Curacao
- Dominican Republic
- Ecuador
- El Salvador
- Guatemala
- Honduras
- Mexico
- Nicaragua
- Panama
- Paraguay
- Peru
- Surinam
- Trinidad and Tobago
- USA
- Uruguay
- Venezuela
- Bahrain
- Bangladesh
- Brunei
- Cambodia
- China
- Hong Kong SAR
- India
- Indonesia
- Iraq
- Japan
- Jordan
- Kuwait
- Laos
- Lebanon
- Malaysia
- Oman
- Pakistan
- Philippines
- Qatar
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Taiwan, China
- Thailand
- UAE
- Vietnam
- Yemen
- Angola
- Cape Verde
- Egypt
- Guinea-Bissau
- Mozambique
- São Tomé and Príncipe
Medion Grifols Diagnostics AG
Medion Grifols Diagnostics continues a tradition in immunohematology that began 60 years ago with Merz and Dade. After refounding in 2006 as Medion Diagnostics AG with legal domicile in Switzerland, the company name was changed in 2010 to Medion Grifols Diagnostics upon acquisition through Grifols.
Medion Grifols Diagnostics manufactures and distributes Reagent Red Blood Cells, Antisera, Controls for DG Gel and conventional tube technique and MDmulticard Reagents. Over the years, our products have been benchmarking the field of immunohematology. In the last two decades, the portfolio was enhanced by novel proprietary technology (MDmulticard) and dedicated product developments for manual and automated Grifols DG Gel technique.
Bonnstrasse, 9
CH-3186 Düdingen
SWITZERLAND
Contact information
Tel: +41 26 492 85 11
Fax: +41 26 492 86 57
E-mail: info@medion-diagnostics.ch
Notification of adverse reactions
To report an adverse drug reaction click here
Do you want to know more about one of the leading healthcare companies? Here you will find all the information about Grifols and our commitment to improving the health and well-being of people around world.